Latest News about SGHT
Recent news which mentions SGHT
Stocks That Hit 52-Week Lows On Tuesday
April 26, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
April 21, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
April 19, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Friday
April 01, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
March 31, 2022
From Benzinga
51 Biggest Movers From Yesterday
March 31, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
March 30, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Friday
March 25, 2022
From Benzinga
Sight Sciences' Q4 Earnings, FY22 Guidance Beat Street View
March 25, 2022
From Benzinga
Sight Sciences, Inc. (SGHT) Q4 2021 Earnings Call Transcript
March 25, 2022
Tickers
SGHT
From Motley Fool
Earnings Scheduled For March 24, 2022
March 24, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
March 15, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 3, 2022
February 03, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
January 19, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
January 18, 2022
From Benzinga
Here's What Investors Need to Know About Sight Sciences Stock
January 12, 2022
Tickers
SGHT
From Motley Fool
Should Investors Consider Sight Sciences Stock?
January 10, 2022
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For January 7, 2022
January 07, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
January 05, 2022
From Benzinga
FDA Approves Sight Sciences' TearCare System For Common Eye Condition
December 22, 2021
Tickers
SGHT
From Benzinga
58 Biggest Movers From Yesterday
December 14, 2021
From Benzinga
40 Stocks Moving In Monday's Mid-Day Session
December 13, 2021
From Benzinga
Sight Sciences, Inc. (SGHT) Q3 2021 Earnings Call Transcript
November 12, 2021
Tickers
SGHT
From Motley Fool
The Daily Biotech Pulse: Eisai-Gilead Tout Positive Phase 2 Data For New Alzheimer's Treatment, Compugen Spikes On Bristol-Myers Investment, Vaxxinity Debuts
November 11, 2021
From Benzinga
FDA Clears Sight Sciences' Trial Of Canaloplasty Combined With Cataract Surgery To Lower Ocular Pressure
November 11, 2021
From Benzinga
From Benzinga
3 Stocks Insiders Are Buying
October 21, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.